|
14 December 2018 |
14 November 2018 |
07 November 2018 Long-delayed EU strategy on hormone disrupting chemicals - roll out is matter of urgencyChemicals which change our hormonal system, so-called endocrine disrupting chemicals (EDCs), are linked to severe health problems, including infertility, obesity, cancer and genital malformations. Today, the European Commission published a strategy on how the EU can address EDCs – a long overdue update to an earlier 1999 strategy. |
Safety Topics
Our work areas
Dangerous substances contained in everyday products such as soaps, toothpaste and shampoo may cause allergies, cancer, disrupt the hormonal system or damage the environment. Among these chemicals are nanomaterials which are increasingly used in consumer products, although the risks they may pose to human health and the environment have not been sufficiently assessed.
Unsafe ‘CE mark’ products continue to be found on the European market. The high number of product safety warnings and product recalls show the need to revise general and sector-specific product safety legislation in order to adequately cover all risks which may be posed by products. Market surveillance and control activities are insufficient to ensure the highest level of safety possible and the level of enforcement is not yet the same across the EU.
Our objectives
- Improve the general safety of products sold on the EU market and establish a European accident and injury database
- Minimise exposure for consumers and the environment to dangerous chemicals
- Adequately and urgently address the potential risks posed by harmful chemicals including nanotechnologies and hormone disrupting chemicals
